Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of mTOR InhibitorsOlga Millán, Eberhard Wieland, Pierre Marquet, et al.
Wiener Medizinische Wochenschrift (1946)|August 28, 2025
[Analysis of lipid levels in medical laboratories in Germany from 2017 to 2022 considering the impact of COVID-19 lockdown measures]Nathalie Eckel, Gergely Bodis, Eberhard Wieland, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerabilityMaria Shipkova, Victor William Armstrong, Michael Oellerich, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 29, 2011
Impact of lipid apheresis on Egr-1, c-Jun, c-Fos, and Hsp70 gene expression in white blood cellsVolker Schettler, Katrin Völker, Egbert G Schulz, et al.
Therapeutic Drug Monitoring|January 28, 2003
Acyl glucuronide drug metabolites: toxicological and analytical implicationsMaria Shipkova, Victor William Armstrong, Michael Oellerich, et al.
Clinical Biochemistry|September 12, 2009
The acyl glucuronide metabolite of mycophenolic acid induces tubulin polymerization in vitroHorst Feichtiger, Eberhard Wieland, Victor W Armstrong, et al.
Therapeutic Drug Monitoring|January 1, 2010
Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assayMaria Shipkova, Ekkehard Schütz, Ingo Besenthal, et al.
Pageof 6